Sumatriptan And Naproxen Sodium Tablet, Film Coated
Product Images NDC 16714-891

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan And Naproxen Sodium (NDC 16714-891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sumatriptan-and-naproxen-figure1 (Spl Sumatriptan And Naproxen Figure1)

A line graph titled 'Percentage of Adult Patients with Initial Headache Pain Relief within 2 Hours,' showing four curves representing treatments: Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg, Sumatriptan 85 mg, Naproxen Sodium 500 mg, and placebo. The x-axis is labeled 'Hours Postdose' (0 to 2 hours), and the y-axis is labeled 'Percentage of Patients with Relief' (0%-100%). The graph compares the percentage of patients experiencing headache relief over time for each treatment group.*

FDA Label Image

Spl-sumatriptan-and-naproxen-figure2 (Spl Sumatriptan And Naproxen Figure2)

A line graph titled 'Estimated Probability of Adults Taking a Rescue Medication over the 24 Hours following the First Dose.' The x-axis represents hours postdose from 0 to 24, and the y-axis shows the percentage of patients taking a rescue medication from 0% to 100%. Four lines represent different treatments: Placebo, Naproxen, Sumatriptan, and Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg. The graph depicts the percentage of patients taking rescue medication over time, with Placebo having the highest proportion and Sumatriptan and Naproxen Sodium the lowest.*

FDA Label Image

Spl-sumatriptan-and-naproxen-label (Spl Sumatriptan And Naproxen Label)

Label for Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg film-coated tablets. The label indicates the product is prescription only and contains 9 tablets. It is labeled by NorthStar Rx LLC with NDC 16714-891-01. The label includes a note for pharmacists to dispense with a medication guide.*

FDA Label Image

Spl-sumatriptan-and-naproxen-naproxen-sodium-str (Spl Sumatriptan And Naproxen Naproxen Sodium Str)

Chemical structure of naproxen sodium, showing its aromatic rings and sodium carboxylate group, as depicted in the diagram for the active ingredient in Sumatriptan and Naproxen Sodium tablets.*

FDA Label Image

Spl-sumatriptan-and-naproxen-sumatriptan-str (Spl Sumatriptan And Naproxen Sumatriptan Str)

Chemical structure of the active ingredient sumatriptan, showing its molecular composition including a sulfonamide group and a tryptamine core, depicted alongside a molecular fragment representing naproxen sodium."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.